184 related articles for article (PubMed ID: 31796052)
21. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
22. Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.
Yu SY; Hong LC; Feng J; Wu YT; Zhang YZ
Tumour Biol; 2016 Jul; 37(7):8923-30. PubMed ID: 26753958
[TBL] [Abstract][Full Text] [Related]
23. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
Joshi H; Vastrad B; Vastrad C
J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
[TBL] [Abstract][Full Text] [Related]
24. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
Wang M; Zhang H; Heng X; Pang Q; Sun A
Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
[TBL] [Abstract][Full Text] [Related]
25. Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas.
Zhu H; Guo J; Shen Y; Dong W; Gao H; Miao Y; Li C; Zhang Y
Clin Cancer Res; 2018 Nov; 24(22):5757-5766. PubMed ID: 29980532
[No Abstract] [Full Text] [Related]
26. Integrative proteomics and transcriptomics revealed that activation of the IL-6R/JAK2/STAT3/MMP9 signaling pathway is correlated with invasion of pituitary null cell adenomas.
Feng J; Yu SY; Li CZ; Li ZY; Zhang YZ
Mol Cell Endocrinol; 2016 Nov; 436():195-203. PubMed ID: 27465831
[TBL] [Abstract][Full Text] [Related]
27. Telomere length and TERT abnormalities in pituitary adenomas.
Boresowicz J; Kober P; Rusetska N; Maksymowicz M; Goryca K; Kunicki J; Bonicki W; Bujko M
Neuro Endocrinol Lett; 2018 Mar; 39(1):49-55. PubMed ID: 29803207
[TBL] [Abstract][Full Text] [Related]
28. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
[TBL] [Abstract][Full Text] [Related]
29. Computational analysis identifies invasion-associated genes in pituitary adenomas.
Cao C; Wang W; Ma C; Jiang P
Mol Med Rep; 2015 Aug; 12(2):1977-82. PubMed ID: 25824863
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas.
Liu W; Matsumoto Y; Okada M; Miyake K; Kunishio K; Kawai N; Tamiya T; Nagao S
J Med Invest; 2005 Aug; 52(3-4):151-8. PubMed ID: 16167532
[TBL] [Abstract][Full Text] [Related]
31. Elevated cell invasion is induced by hypoxia in a human pituitary adenoma cell line.
Yoshida D; Teramoto A
Cell Adh Migr; 2007; 1(1):43-51. PubMed ID: 19262092
[TBL] [Abstract][Full Text] [Related]
32. RIZ1 and histone methylation status in pituitary adenomas.
Xue Y; Chen R; Du W; Yang F; Wei X
Tumour Biol; 2017 Jul; 39(7):1010428317711794. PubMed ID: 28718376
[TBL] [Abstract][Full Text] [Related]
33. Association of expression of Leucine-rich repeats and immunoglobulin-like domains 2 gene with invasiveness of pituitary adenoma.
Zhang H; Yan Q; Xu S; Ou Y; Ye F; Wang B; Lei T; Guo D
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):520. PubMed ID: 21823015
[TBL] [Abstract][Full Text] [Related]
34. Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma.
Yu C; Li J; Sun F; Cui J; Fang H; Sui G
Med Sci Monit; 2016 Dec; 22():5101-5108. PubMed ID: 28012286
[TBL] [Abstract][Full Text] [Related]
35. Research Advances in Pituitary Adenoma and DNA Methylation.
Wei ZQ; Li Y; Li WH; Lou JC; Zhang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Aug; 38(4):475-9. PubMed ID: 27594164
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
[TBL] [Abstract][Full Text] [Related]
37. Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness.
Takino H; Herman V; Weiss M; Melmed S
J Clin Endocrinol Metab; 1995 May; 80(5):1733-8. PubMed ID: 7745027
[TBL] [Abstract][Full Text] [Related]
38. DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors.
García-Martínez A; Sottile J; Sánchez-Tejada L; Fajardo C; Cámara R; Lamas C; Barberá VM; Picó A
J Clin Endocrinol Metab; 2019 Apr; 104(4):1272-1282. PubMed ID: 30423170
[TBL] [Abstract][Full Text] [Related]
39. Expression of p18(INK4C) is down-regulated in human pituitary adenomas.
Hossain MG; Iwata T; Mizusawa N; Qian ZR; Shima SW; Okutsu T; Yamada S; Sano T; Yoshimoto K
Endocr Pathol; 2009; 20(2):114-21. PubMed ID: 19401813
[TBL] [Abstract][Full Text] [Related]
40. Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas.
Li S; Zhang Z; Xue J; Guo X; Liang S; Liu A
Med Sci Monit; 2015 Aug; 21():2433-8. PubMed ID: 26286316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
